All three fluoroindolocarbazoles are more potent than rebeccamycin against P388 leukemia by ip route in murine model.
(Received for publication June 26, 2000) Saccharothrix aerocolonigenes ATCC39243 produces an indolocarbazole antitumor agent rebeccamycin under submerged fermentation conditions. Adding DL-6-fluorotryptophan to culture of S. aerocolonigenes ATCC 39243 induces the formation of two novel indolocarbazoles, fluoroindolocarbazoles A and B. Feeding DL-5-fluorotryptophan to culture of S. aerocolonigenes ATCC 39243 induces the production of a novel indolocarbazole, fluoroindolocarbazole C. These fluoroindolocarbazoles have been isolated from culture broth and purified to homogeneity by vacuum liquid chromatography and column chromatography.
All three fluoroindolocarbazoles are more potent than rebeccamycin against P388 leukemia by ip route in murine model.
Rebeccamycin is an indolocarbazole antitumor antibiotic isolated from culture of S. aerocolonigenes ATCC39243°.
Rebeccamycin has a broad spectrum of in vivo activity in tumor-bearing murine models1\ It consists of a chlorinated indolocarbazole chromophore to which attached a A'-Omethylglucose via an TV-glycosidic linkage (Fig. 1) In a previous paper5), we reported the production and isolation of a novel bromoindolocarbazole The fluorine atom has the strongest electronegativity among all the elements and the C-F bond energy is greater than that of the C-H or C-Cl bond15). The fluorinated derivatives may therefore possess different biological activities as compared to the parent compound. In this paper, we describe the production, isolation and structure determination of three fluoroindolocarbazoles from cultures of S. aerocolonigenes ATCC 39243 supplemented with DL-5 -fluorotryptophan or DL-6-fluorotryptophan.
Materials and Methods

General Procedures
The UV spectra were recorded on a Hewlett-Packard 8452A diode array spectrophotometer.
IR spectra were recorded on Perkin-Elmer 1800 FTIR spectrometer. FAB-MS spectra were obtained on a Kratos MS 25 mass spectrometer. !H-NMR (360 MHz) and 13C-NMR (90 MHz) spectra were obtained on a Bruker model AM-3000 spectrometer. Additional-NMR spectra were acquired on a
Bruker AM-500 operating at 500.13mHz at 298K, The spectra were obtained in "100%" DMSO-J6and referenced to this solvent. Long range heteronuclear coupling information was obtained using COLOC experiments utilizing mixing times of 0.06 and 0.08s. The coupling constants were determined by direct measurement from the one-dimensional spectra. The numberof attached protons to each carbon was determined by a DEPT-135experiment.
Microorgani sm
The rebeccamycin-producing microorganism was 
Media and Fermentation Conditions
To prepare an inoculum for the production phase, 4 ml of the frozen vegetative stock was transferred to a 500-ml flask containing 100 ml of vegetative mediumconsisting of glucose 3%, Pharmamedia 1%, Nutrisoy 1% and CaCO3 0.3%. This vegetative culture was incubated at 28°C on a rotary shaker at 250rpm. After 48 hours, 3-ml aliquots were transferred to 500-ml flasks containing 100ml of medium DF-36. Medium DF-36 consists of starch 1%, Lthreonine 0.25%, MgSO4-7H2O 0.1%, KH2PO4 0.2% and CaCO3 0.2%. The production cultures were incubated at 28°C and 250rpm for 6 days. For the production of fluoroindolocarbazoles, DL-5-fluorotryptophan or dl-6-fluorotryptophan wasadded to the production cultures at a final concentration of 1 mg/ml at 48 hours.
Extraction and Analytical Methods
The production of rebeccamycin and fluoroindolocarbazoles were monitored by HPLC using a C-18 semi-preparative HPLCusing a WhatmanPartisil 10 ODS-3 column (10mmX50em) and an isocratic solvent system consisting of 0.1 M NH4OAc/THF (3 :2). At a flow rate of 4 ml/minute, the major rebeccamycin analog was eluted at 39 minutes. The fractions containing this analog were pooled, and upon drying yielded 23mg of bright yellow solid designated as fluoroindolocarbazole C.
Antitumor Assay
The general procedures used to assess antitumor activity using the P388 leukemia model have been described16 '17 were four to six mice in each treatment group and 10 mice in the control groups. Each compound was administered at several dose levels, usually at 50% decrements. Efficacy was evaluated by determining the relative median life spans of treated (T) and control mice and expressing the ratios (after multiplying by 100) in terms of %T/C values. A T/C value of > 125%was considered active.
Results
Production of Fluoroindolocarbazoles by Directed Biosynthesis
During the course of our studies on the regulation and biosynthesis of rebeccamycin by S. aerocolonigenes ATCC 392434'18), a defined medium DF-36 was developed for the production of rebeccamycin. When PL-6-fluorotryptophan was added at day 2 of the fermentation to yield a final concentration of 1 mg/ml, two new major metabolites (fluoroindolocarbazoles A and B) with Rts of 15.7 and 22.4 minutes respectively, were detected in the mycelial extract by HPLCanalysis. The UV spectra of these metabolites (Table 1 and 2) were very similar to that of rebeccamycin indicating that these metabolites have similar chromophores as rebeccamycin. Rebeccamycin (Rt of 18.1 minutes) was not detected in the above fermentation by HPLCanalysis. WhenDL-5-fluorotryptophan was added at day 2 of the fermentation yielding a final concentration of 1 mg/ml, one major metabolite (fluoroindolocarbazole C) with Rt of 9.9 minutes was detected in the mycelial extract by HPLC analysis. This new metabolite also has a UV spectrum (Table 3 ) similar to rebeccamycin and is another new analog. Based on the spectral data, it was readily determined that fluoroindolocarbazole A has the structure 2,10-difluoro-1,1 1-dideschloro-rebeccamycin as shown in Fig. 1 .
Physico-chemical Properties of Fluoroindolocarbazole B
The physico-chemical properties of fluoroindolocarbazole B are summarized in Table 3 Assignment of resonances for the sugar portion was made using the COSYexperiment aided by HETCORand COLOCexperiments. The only problem encountered for the sugar was the assignments of carbon resonances at 67.6 and 78.7ppm. The corresponding methine protons both resonate at 3.95ppm (4'-H and 5'-H) and the neighboring proton at 3.83 ppm (6'-H) showed long range couplings to both of these carbons, confusing the issue. Hence, a comparison to a model compound /?-D-glucopyranose19) was necessary to assign the carbon chemical shifts.
Based on the spectral data, it was determined that fluoroindolocarbazole B has the structure 2,10-difluorol , l l -dideschloro-4'-0-desmethylrebeccamycin as shown in Table 4 . By a similar line of reasoning used for deducing the structures of fluoroindolocarbazoles A and B, the structure of fluoroindolocarbazole C was determined to be 3,9-difluoro-l,l l-dideschloro-4'-(9-desmethylrebeccamycin as shown in Fig. 1 rebeccamycin has been found to be inactive on occasion at 32 mg/kg1}, or minimally effective at 20 mg/kg (W. C. Rose; unpublished data). Such data would suggest at least a 20-40 fold difference in minimal effective potency between rebeccamycin and the two analogs. In a pilot study in which only a cursory evaluation of fluoroindolocarbazole C was performed (using only four mice per treatment group), the derivative achieved a maximumT/C value of 175% at 30mg/kg, and was active at a dose as low as lOmg/kg (Table 6 ). In this experiment, rebeccamycin achieved a maximumT/C value of 155%at 7 200-300mg/kg. These data also suggest that a 6.7-10 fold and 2-3 fold difference in optimal doses and minimal effective potency, respectively, between rebeccamycin and fluoroindolocarbazole C.
Discussion
In this publication we report the production of three novel fluoroindolocarbazoles in cultures of S. aerocolonigenes ATCG39243 by directed biosynthesis.
Wehave previously established that tryptophan is one of the biosynthetic precursors for rebeccamycin4). A defined mediumthat shows a distinct trophophase and idiophase has also been developed4). The distinct phasing was considered promising for efficient utilization of added precursors or precursor analogs, a postulation that was shown to be correct. Adding DL-6-fluorotryptophan to a culture of S. aerocolonigenes ATCC 39243 at the start of idiophase (~2 days) induced the formation of two novel indolocarbazoles, fluoroindolocarbazoles A All treatments were administered once, ip, on day 1 post-leukemia (106 cells, ip) implant. There were 6 mice per treatment group and 10 mice in each saline-treated control group. 
